Current Pharmaceutical Design
Title:Recent Advances towards the Treatment of Depressive Disorders
Volume: 24 Issue: 22
Author(s): Kefeng Li and Xu Wang
Affiliation:
Export Options
About this article
Cite this article as:
Li Kefeng and Wang Xu , Recent Advances towards the Treatment of Depressive Disorders, Current Pharmaceutical Design 2018; 24 (22) . https://dx.doi.org/10.2174/138161282422181019144120
DOI https://dx.doi.org/10.2174/138161282422181019144120 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
29
8
2
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Alcohol Drinking, Apolipoprotein Polymorphisms and the Risk of Cardiovascular Diseases
Current Neurovascular Research Prospect of a Dopamine Contribution in the Next Generation of Antidepressant Drugs: The Triple Reuptake Inhibitors
Current Drug Targets Circadian Rhythm and Melatonin in the Treatment of Depression
Current Pharmaceutical Design Topical Targeting Therapies for Sexually Transmitted Diseases
Current Nanoscience Disease Modifying Therapeutic Strategies in Alzheimers Disease Targeting the Amyloid Cascade
Current Neuropharmacology The NR2B Subtype of NMDA Receptor: A Potential Target for the Treatment of Alcohol Dependence
Current Drug Targets - CNS & Neurological Disorders Advances in Whole Genome Sequencing Technology
Current Pharmaceutical Biotechnology An fMRI-EEG Integrative Method with Model Selection Procedures for Reconstruction of Multiple Cortical Activities
Neuroscience and Biomedical Engineering (Discontinued) CatbNet: A Multi Network Analyzer for Comparing and Analyzing the Topology of Biological Networks
Current Genomics Non-Derivatization Method for the Determination of Gabapentin in Pharmaceutical Formulations, Rat Serum and Rat Urine using High Performance Liquid Chromatography Coupled with Charged Aerosol Detection
Current Analytical Chemistry Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Commentary [Research Highlights (Making Sense Out of Antisense in Huntington’s Disease)]
CNS & Neurological Disorders - Drug Targets Toward a Molecular Understanding of the Interaction of Dual Specificity Phosphatases with Substrates: Insights from Structure-Based Modeling and High Throughput Screening
Current Medicinal Chemistry The Role of Phosphorylation in Synucleinopathies: Focus on Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Cannabinoid Receptor Type 2 Activation Yields Delayed Tolerance to Focal Cerebral Ischemia
Current Neurovascular Research A Molecular Guidance System Based Upon Target Genes, Nuclear Receptors and Ligands Applied to Drug Discovery and Prediction of Toxicity
Mini-Reviews in Medicinal Chemistry Cognitive-Behavioral Therapy for Youth with Obsessive-Compulsive and Related Disorders
Current Psychiatry Reviews Role of Flavonoids in Neurodegenerative Diseases: Limitations and Future Perspectives
Current Topics in Medicinal Chemistry Drug and Non-drug Treatment of Tourette Syndrome
Current Drug Therapy Curcumin Targets in Inflammation and Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets